| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Aridis Pharmaceuticals, Inc. (ARDS) has 0 insiders with recent SEC Form 4 filings, including 8 buys and 0 sells. ARDS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 24, 2024 | Truong Vu | CEO | Buy | 714,286 | $0.07 | $50,000.02 | +107.5% | |
| Jun 24, 2024 | Patzer Eric | Director | Buy | 714,286 | $0.07 | $50,000.02 | +419.4% | |
| Sep 7, 2021 | Jafri Hasan | Chief Medical Officer | Buy | 5,100 | $4.15 | $21,147.00 | +63.7% | |
| Jul 27, 2021 | Truong Vu | CEO | Buy | 5,000 | $5.11 | $25,550.00 | +0.7% | |
| Jul 27, 2021 | Patzer Eric | Director | Buy | 5,175 | $4.84 | $25,047.00 | +0.7% | |
| Jul 27, 2021 | Hamilton John F | Director | Buy | 2,000 | $4.87 | $9,740.00 | New |